In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dividend Kings have increased dividends for 50+ years, indicating stable, profitable operations. Investing in Dividend Kings offers reliable income, suitable for retirement portfolios. Target, Altria, ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance ...

Trump’s Venezuela gambit has the potential to impact global oil markets, reshape great-power alliances, and undermine norms. Advertisement From 'The Moment' to 'The Drama,' here are the most ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Investopedia / Ryan Oakley The cost of labor ...

The year 2025 will be remembered as a remarkable one for players. From Clair Obscur Expedition 33 to Donkey Kong Bananza, nearly every genre received a title that stood out from the rest. With a ...

Abstract: Projection-aggregation decoding provides state-of-the-art performance for decoding Reed-Muller codes. This type of decoding relies on projecting onto subspaces, decoding the projections, and ...